Ignite Creation Date:
2024-05-06 @ 12:52 PM
Last Modification Date:
2024-10-26 @ 1:05 PM
Study NCT ID:
NCT03868423
Status:
WITHDRAWN
Last Update Posted:
2022-02-18
First Post:
2019-02-04
Brief Title:
Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers
Sponsor:
Organization:
Ohio State University Comprehensive Cancer Center